Imexpharm Corp (IMP) — Free Cash Flow Generation Index

Latest as of March 2026: 0.92x

Imexpharm Corp (IMP) has a Free Cash Flow Generation Index of 0.92x as of March 2026. Free cash flow of ₫95.71 Billion represents 1% of operating cash flow (₫103.49 Billion). Read IMP liabilities breakdown for a breakdown of total debt and financial obligations.

FCF Generation Index

0.92x
Free Cash Flow / Operating CF

Free Cash Flow

₫95.71 Billion
VND

Operating Cash Flow

₫103.49 Billion
VND

Capital Expenditures

₫7.79 Billion
VND

Imexpharm Corp Free Cash Flow Generation Index (2019–2025)

Historical FCF Generation Index trend for Imexpharm Corp across 6 annual periods. Explore capital reinvestment ratio of Imexpharm Corp to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Imexpharm Corp (2019–2025)

Year-by-year Free Cash Flow Generation Index for Imexpharm Corp. For the full company profile including market capitalisation, see IMP market cap overview.

Year FCG Index Free Cash Flow (VND) Operating CF Capital Expenditures YoY Change
2025 0.50x ₫27.29 Billion ₫54.17 Billion ₫26.88 Billion ▼ -8.8%
2024 0.55x ₫119.50 Billion ₫216.27 Billion ₫96.77 Billion ▼ -25.1%
2022 0.74x ₫279.25 Billion ₫378.60 Billion ₫99.35 Billion ▼ -4.8%
2021 0.77x ₫182.02 Billion ₫234.88 Billion ₫52.86 Billion ▲ +442.9%
2020 -0.23x ₫-16.53 Billion ₫73.15 Billion ₫89.68 Billion ▲ +76.7%
2019 -0.97x ₫-64.53 Billion ₫66.59 Billion ₫131.12 Billion
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).